1. Home
  2. HWH vs BNGO Comparison

HWH vs BNGO Comparison

Compare HWH & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HWH International Inc.

HWH

HWH International Inc.

HOLD

Current Price

$1.81

Market Cap

11.0M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.18

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWH
BNGO
Founded
2021
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.0M
12.5M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
HWH
BNGO
Price
$1.81
$1.18
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
44.4K
109.3K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
47.37
94.50
EPS
N/A
N/A
Revenue
$866,926.00
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.88
$1.00
52 Week High
$7.77
$5.50

Technical Indicators

Market Signals
Indicator
HWH
BNGO
Relative Strength Index (RSI) 67.91 53.64
Support Level $0.97 $1.10
Resistance Level $1.81 $1.19
Average True Range (ATR) 0.14 0.05
MACD 0.03 0.01
Stochastic Oscillator 81.51 79.09

Price Performance

Historical Comparison
HWH
BNGO

About HWH HWH International Inc.

HWH International Inc and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore. The Company is presently developing Hapi Marketplace, a business-to-consumer platform featuring diverse product categories, and Hapi Wealth Builder, an educational program focused on wealth-building strategies.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: